New therapeutic options, like use of Inositols (i.e., insulin-sensitizing compounds) for assisted reproduction, might improve the chance of obtaining qualitatively good oocytes from CCSs at risk of ovarian dysfunction [42]. This evidence concerns the gene INS and ovarian dysfunction.